Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis.
Corrado PelaiaNicola LombardoMaria Teresa BuscetiGiovanna PiazzettaClaudia CrimiCecilia CalabreseAlessandro VatrellaGirolamo PelaiaPublished in: Journal of asthma and allergy (2021)
The results of this real-life study suggest that dupilumab can be utilized in both allergic and nonallergic patients with severe asthma and nasal polyposis as a valuable add-on biological therapy with rapid onset of action.